Oral lesions in children with perinatally acquired human immunodeficiency virus infection

Journal of Oral Pathology and Medicine

Volumn 28, Issue 2, 1999, Pages 49-53

  Nicolatou, Ourania ^a,c   Theodoridou, Maria ^b   Mostrou, Glyceria ^b   Velegraki, Aristea ^b   Legakis, Nicholas J ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

Children; HIV infection; Oral lesions

Indexed keywords

CANDIDA; CLONE; HUMAN IMMUNODEFICIENCY VIRUS; MYCOSIS; PATHOGENESIS; THRUSH;

EID: 0033081432     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb01995.x     Document Type: Article

References (27)

1. SCHIODT M, BAKILANA PB, HIZA JFR, et al. Oral candidiasis and hairy leukoplakia correlate with HIV infection in Tanzania. Oral Surg Oral Med Oral Pathol 1990; 69: 591-6.
2. DODD CL, GREENSPAN D, KATZ M, WESTENHOUSE JL, FEIGAL DW, GREENSPAN JS. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 1991; 5: 1339-43.
3. GLICK M, MUZYKA BC, LURIE D, SALKIN LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994; 77: 344-9.
4. LIFSON AR, HILTON JF, WESTENHOUSE JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994; 8: 73-9.
5. OLESKE J, MINNEFOR A, COOPER JR R, et al. Immune deficiency syndrome in children. JAMA 1993; 249: 2345-9.
6. LEGGOTT PJ. Oral manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol 1992; 73: 187-92.
7. KETCHEM L, BERKOWITZ RJ, MCILVEEN L, FORRESTER D, RAKNSAN T. Oral findings in HIV-seropositive children. Pediatr Dent 1990; 12: 143-6.
8. TOVO PA, DE MARTINO M, GABIANO C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992; 339: 1249-53.
9. KATZ MH, MASTRUCCI MT, LEGGOTT PJ, WESTENHOUSE J, GREENSPAN JS, SCOTT GB. Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus infection. AJDC 1993; 147: 45-8.
10. RAMOS-GOMEZ FJ, HILTON JF, CANCOLA AJ, GREENSPAN D, GREENSPAN JS, MALDONADO YA. Risk factors for HIV-related orofacial soft-tissue manifestations in children. Pediatr Dent 1996; 18: 121-6.
11. RAMOS-GOMEZ FJ. Oral aspects of HIV infection in chidren. Oral Dis 1997; 3: S31-S35.
12. MONIACI D, CAVALLARI M, GRECO D, BRUATTO M, TOVO PA, SINICCO A. Oral lesions in children born to HIV-1 positive women. J Oral Pathol Med 1993; 22: 8-11.
13. DEL TORO A, BERKOWITZ R, MEYEROWITZ C, FRENKEL LM. Oral findings in asymptomatic (P-1) and symptomatic (P-2) HIV-infected children. Pediatr Dent 1996; 18: 114-6.
14. European Centre for the Epidemiological Monitoring of AIDS. European case definition for AIDS surveillance in children. Revision 1995. HIV/AIDS Surveillance in Europe, 1995 Report No. 48.
15. AXELL T, AZUL AM. CHALLACOMBE SJ, et al. Classification and diagnostic criteria for oral lesions in HIV-infection. J Oral Pathol Med 1993; 22: 289-91.
16. PFALLER MA, HOUSTON A, COFFMAN S. Application of the CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol 1996; 34: 58-61.
17. COLEMAN DC, SULLIVAN DJ, BENNETT DE, et al. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557-67.
18. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27 - T NCCLS, Villanova PA, 1995.
19. VELEGRAKI A, PAPALAMBROU P, SOREMI S, LEGAKIS NJ. Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts. Eur J Clin Microbiol Infect Dis 1996; 15: 854-60.
20. BARONE R, FICARRA G, GAGLIOTI D, ORSI A, MAZZOTTA F. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 1990; 69: 169-73.
21. MONIACI D, GRECO D, FLECCHIA G, RAITERI R, SINICCO A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990; 19: 477-81.
22. MCCARTHY GM, MACKIE ID, KOVAL J, SANDHU HS, DALEY TD. Factors associated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 1991; 20: 332-6.
23. ROYCE RA, LUCKMANN RS, FUSARO RE, WINKELSTEIN JR W. The natural history of HIV-1 infection: staging classifications of disease. AIDS 1991; 5: 355-64.
24. ROBINSON PG, CHALLACOMBE SJ, SHEIHAM A, ZAKRZEWSKA JM. Is erythemalous candidiasis associated with advanced HIV disease? Oral Dis 1997; 3: S116-S118.
25. SAMARANAYAKE LP, HOLMSTRUP P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989; 18: 554-64.
26. POWDERLY WG, ROBINSON K, KEATH E. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence of two patterns of recurrence. J Infect Dis 1993; 168: 463-6.
27. REICHART PA, WEIGEL D, SCHMIDT WESTHAUSEN, POHLE HD. Exfoliative cheilitis (EC) in AIDS: association with Candida infection. J Oral Pathol Med 1997; 26: 290-3.